Systemic and ocular complications of sulfur mustard: A panoramic review

References

• Aasted A, Darre E, Wulf HC. (1987). Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann Plast Surg 19:330–333.
   PubMed Web of Science ®Google Scholar
• Amir A, Turetz J, Chapman S, Fishbeine E, Meshulam J, Sahar R, Liani H, Gilat E, Frishman G, Kadar T. (2000). Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J Appl Toxicol 20(suppl 1):S109–S114.
   Google Scholar
• Arroyo CM, Schafer RJ, Kurt EM, Broomfield CA, Carmichael AJ. (2000). Response of normal human keratinocytes to sulfur mustard: cytokine release. J Appl Toxicol 20:S63–S72.
   PubMed Web of Science ®Google Scholar
• Assennato G, Ambrosi F, Sivo D. (1997). [Possible long-term effects on the respiratory system of exposure to yperite of fishermen]. Med Lav 88:148–154.
   PubMedGoogle Scholar
• Azizi F, Amini M, Arbab P. (1993). Time course of changes in free thyroid indices, rT3, TSH, cortisol and ACTH following exposure to sulfur mustard. Exp Clin Endocrinol 101:303–306.
   PubMedGoogle Scholar
• Azizi F, Keshavarz A, Roshanzamir F, Nafarabadi M. (1995). Reproductive function in men following exposure to chemical warfare with sulfur mustard. Med War 11:34–44.
   PubMedGoogle Scholar
• Bakhtavar K, Sedighi N, Moradi Z. (2008). Inspiratory and expiratory high-resolution computed tomography (HRCT) in patients with chemical warfare agents exposure. Inhal Toxicol 20:507–511.
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M. (2005). The pharmacology, toxicology, and medical treatment of sulfur mustard poisoning. Fundam Clin Pharmacol 19:297–315.
   PubMed Web of Science ®Google Scholar
• Balali-Mood M, Hefazi M. (2006). Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99:273–282.
   PubMed Web of Science ®Google Scholar
• Bignold LP. (2006). Alkylating agents and DNA polymerases. Anticancer Res 26:1327–1336.
   PubMedGoogle Scholar
• Blaha M, Bowers W, Kohl, JJr., DuBose D, Walker J, Alkhyyat A, Wong G. (2000). Effects of CEES on inflammatory mediators, heat shock protein 70A, histology and ultrastructure in two skin models. J Appl Toxicol 20:S101–S108.
   PubMedGoogle Scholar
• Bobb AJ, Arfsten DP, Jederberg WW. (2005). N-acetyl-L-Cysteine as prophylaxis against sulfur mustard. Mil Med 170:52–56.
   PubMed Web of Science ®Google Scholar
• Borak J, Sidell FR. (1992). Agents of chemical warfare: sulfur mustard. Ann Emerg Med 21:303–308.
   PubMed Web of Science ®Google Scholar
• Bullman T, Kang H. (2000). A fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gas. Ann Epidemiol 10:333–338.
   PubMed Web of Science ®Google Scholar
• Buscher H. (1944). Green and Yellow Cross: Special Pathology and Therapy of Injuries Caused by the Chemical War Materials of the Green Cross Group (Phosgene and Diphosgene) and of the Yellow Cross Group (Mustard Gas and Lewisite). Cincinnati, OH: Kettering Laboratory.
   Google Scholar
• Calvet JH, Planus E, Rouet P, Pezet S, Levame M, Lafuma C, Harf A, D’Ortho MP. (1999). Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am J Physiol 276:L754–L762.
   Google Scholar
• Dacre JC, Goldman M. (1996). Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev 48:289–326.
   PubMed Web of Science ®Google Scholar
• Demetrius E, Hinsley D, Rice P. (2002). Chemical weapons regular review. BMJ 2–9:332–335.
   PubMedGoogle Scholar
• DH Department of Health. (2007). Acute management of mustard gas injuries of the eye. 3–11. DH Department of Health.
   Google Scholar
• Drasch G, Kretschmer E, Kauert G, von Meyer L. (1987). Concentrations of mustard gas [bis(2-chloroethyl)sulfide] in the tissues of a victim of a vesicant exposure. J Forensic Sci 32:1788–1793.
   PubMed Web of Science ®Google Scholar
• Dua HS, Saini JS, Zuara-Blanco A, Gupta P. (2000). Limbal stem cell deficiency: concept, aetiology, clinical presentation, diagnosis and management. Indian J Ophthalmol 48:83–92.
   PubMedGoogle Scholar
• Eisenkraft A, Luria S, Robenshtok E, Hourvitz A. (2003). [Using thalidomide against pathological neovascularization]. Harefuah 142: 212–216, 237.
   PubMedGoogle Scholar
• Etezad-Razavi M, Mahmoudi M, Hefazi M, Balali-Mood M. (2006). Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications. Clin Experiment Ophthalmol 34:342–346.
   PubMed Web of Science ®Google Scholar
• Garner JP. (2003). Some recollections of Porton in World War 1. Commentary. J R Army Med Corps 149:138–141.
   PubMedGoogle Scholar
• Gee CJ, Bonkowske J, Kurup SK. (2008). Visual disability in selected acts of terror, warfare, and natural disasters of the last 25 years: a concise narrative review. Am J Disaster Med 3:25–30.
   PubMedGoogle Scholar
• Geraci MJ. (2008). Mustard gas: imminent danger or eminent threat? Ann Pharmacother 42:237–246.
   PubMedGoogle Scholar
• Ghanei M, Vosoghi AA. (2002). An epidemiologic study to screen for chronic myelocytic leukemia in war victims exposed to mustard gas. Environ Health Perspect 110:519–521.
   PubMed Web of Science ®Google Scholar
• Ghasemi H, Ghzanfari T, Babaei M, Soroush M, Yaraee R, Ghassemi-Broumand M, Javadi MA, Foroutan A, Vaez Mahdavi MR, Shams J, Pourfarzam S, Moaiedmohseni S, Jalali Nadoushan MR, Owlia P, Panahi Y, Hassan Z, Faghihzadeh S. (2008). Long-term ocular complications of Sulfur mustard in the civilian victims of Sardasht, Iran. Cutaneous and Ocular Toxicology 27 (4) 317–326.
   PubMed Web of Science ®Google Scholar
• Ghasemi-Broumand M, Karami G, Pourfarzam S, Emadi S, Ghasemi H. (2007). Delayed ophthalmic, respiratory, cutaneous and psychiatric complications of chemical warfare agents on 479 war veterans. Daneshvar Medicine 70:81–92. In Persian.
   Google Scholar
• Ghazanfari T, Faghihzadeh S, Aragizadeh H, Soroush MR, Yaraee R, Hassan ZM, et al., (2009) Sardasht-Iran Cohort Study of Chemical Warfare Victims: Design and Methods, Arch Iranian Med 12 (1): 5–14.
   PubMedGoogle Scholar
• Ghotbi L, Hassan Z. (2002). The immunostatus of natural killer cells in people exposed to sulfur mustard. Int Immunopharmacol 2:981–985.
   PubMed Web of Science ®Google Scholar
• Godwin ED. (1942). War gas injuries of the eye. Cal West Med 57:299–301.
   PubMedGoogle Scholar
• Goozner B, Lutwick LI, Bourke E. (2002). Chemical terrorism: a primer for 2002. J Assoc Acad Minor Phys 13:14–18.
   PubMedGoogle Scholar
• Graham JS, Chilcot RP, Rice P, Milner SM, Hurst CG, Maliner BI. (2005). Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J Burns Wounds 4:e1.
   PubMedGoogle Scholar
• Grando SA. (2003). Mucocutaneous cholinergic system is targeted in mustard-induced vesication. Life Sci 72:2135–2144.
   PubMed Web of Science ®Google Scholar
• Gross CL, Innace JK, Hovatter RC, Meier HL, Smith WJ. (1993). Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol Toxicol 9:259–267.
   PubMed Web of Science ®Google Scholar
• Guignabert C, Taysse L, Calvet JH, Planus E, Delamanche S, Galiacy S, d’Ortho MP. (2005). Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am J Physiol Lung Cell Mol Physiol 289:L67–L74.
   PubMed Web of Science ®Google Scholar
• Hassan ZM, Ebtekar M, Ghanei M, Taghikhani M, Noori Daloii MR, Ghazanfari T. (2006). Immunobiological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol 5:101–108.
   PubMedGoogle Scholar
• Hay A. (2000). Old dogs or new tricks: chemical warfare at the millennium. Med Confl Surviv 16:37–41.
   PubMedGoogle Scholar
• Iyriboz Y. (2004). A recent exposure to mustard gas in the United States: clinical findings of a cohort (n = 247) 6 years after exposure. Med Gen Med 6:4.
   PubMedGoogle Scholar
• Jankowski MK, Schnurr PP, Adams GA, Green BL, Ford JD, Friedman MJ. (2004). A mediational model of PTSD in World War II veterans exposed to mustard gas. J Trauma Stress 17:303–310.
   PubMed Web of Science ®Google Scholar
• Javadi MA, Yazdani S, Kanavi MR, Mohammadpour M, Baradaran-Rafiee A, Jafarinasab MR, Einollahi B, Karimian F, Zare M, Naderi M, Rabei HM. (2007). Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis. Cornea 26:1074–1078.
   PubMed Web of Science ®Google Scholar
• Javadi MA, Yazdani S, Sajjadi H, Jadidi K, Karimian F, Einollahi B, Ja’farinasab MR, Zare M. (2005). Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. Ophthalmology 112:617–625.
   PubMed Web of Science ®Google Scholar
• Kehe K, Balszuweit F, Elmmer J, Kreppel H, Jochum M, Thierman H. (2008). Sulfur mustard research-strategies for the development of improved medical therapy. Eplasty 8:e32.
   PubMedGoogle Scholar
• Kehe K, Reisinger H, Szinicz L. (2000). Sulfur mustard induces apoptosis and necrosis in SCL II cells in vitro. J Appl Toxicol 20:S81–S86.
   PubMedGoogle Scholar
• Kehe K, Szinicz L. (2005). Medical aspects of sulfur mustard poisoning. Toxicology 214:198–209.
   PubMed Web of Science ®Google Scholar
• Keyhani A, Eslami MB, Razavimanesh H. (2007). The short-term effect of mustard gas on the serum immunoglobulin levels. Iran J Allergy Asthma Immunol 6:15–19.
   PubMed Web of Science ®Google Scholar
• Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. (2003). Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45:1136–1143.
   PubMed Web of Science ®Google Scholar
• Khateri S, Organization of Veterans Affairs. (2001). Statistical Views on Late Complications of Chemical Weapons on Iranian CW Victims. The ASA Newsletter.
   Google Scholar
• Kinsey VE, Grant WM. (1946). Determination of the rate of disappearance of mustard gas and mustard intermediates in corneal tissue. J Clin Invest 25:776–779.
   PubMedGoogle Scholar
• Le HQ, Knudsen SJ. (2006). Exposure to a First World War blistering agent. J Emerg Med 23:296–299.
   Google Scholar
• Lefkowitz LJ, Smith WJ. (2002). Sulfur mustard-induced arachidonic acid release is mediated by phospholipase D in human keratinocytes. Biochem Biophys Res Commun 295:1062–1067.
   PubMed Web of Science ®Google Scholar
• Lindsay CD, Rice P. (1996). Assessment of the biochemical effects of percutaneous exposure of sulfur mustard in an in vitro human skin system. Hum Exp Toxicol 15:237–244.
   PubMed Web of Science ®Google Scholar
• Liu DK, Wannemacher RW, Snider TH, Hayes TL. (1999). Efficacy of the topical skin protectant in advanced development. J Appl Toxicol 19:S40–S54.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M. (2005). Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol 5:1479–1485.
   PubMed Web of Science ®Google Scholar
• Mann I. (1944). A study of eighty-four cases of delayed mustard gas keratitis fitted with contact lenses. Br J Ophthalmol 28:441–447.
   PubMedGoogle Scholar
• Meisenberg BR, Melaragno AJ, Monroy RL. (1993). Granulocyte colony stimulating factor (G-CSF) for mustard-induced bone marrow suppression. Mil Med 158:470–474.
   PubMed Web of Science ®Google Scholar
• Merat S, Perez JP, Ruttimann M, Bordier E, Lienhard A, Lenoir B, Pats B. (2003). [Acute poisoning by chemical warfare agent: sulfur mustard]. Ann Fr Anesth Reanim 22:108–118.
   PubMed Web of Science ®Google Scholar
• Meier HL, Millard C, Moser J. (2000). Poly(ADP-ribose) polymerase inhibitors regulate the mechanism of sulfur mustard-initiated cell death in human lymphocytes. J Appl Toxicol 20:S93–S100.
   Google Scholar
• Mellor SG, Rice P, Cooper GJ. (1991). Vesicant burns. Br J Plast Surg 44:434–437.
   PubMedGoogle Scholar
• Mol ME, de Ruit V, Kluivers AW. (1991). Effects of nicotinamide on biochemical changes and microblistering induced by sulfur mustard in human skin organ cultures. Toxicol Appl Pharmacol 107:439–449.
   PubMed Web of Science ®Google Scholar
• Momeni AZ, Aminjavaheri M. (1994). Skin manifestations of mustard gas in a group of 14 children and teenagers: a clinical study. Int J Dermatol 33:184–187.
   PubMed Web of Science ®Google Scholar
• Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. (1992). Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 128:775–780.
   PubMed Web of Science ®Google Scholar
• Moser J, Meier HL. (2000). Comparison of cell size in sulfur mustard-induced death of keratinocytes and lymphocytes. J Appl Toxicol 20:S23–S30.
   PubMedGoogle Scholar
• Munro NB, Talmage SS, Griffin GD, Waters LC, Watson AP, King JF, Hauschild V. (1959). The sources, fate, and toxicity of chemical warfare agent degradation products. Environ Health Perspect 43:933–974.
   Google Scholar
• Naghii MR. (2002). Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil Med 167:573–575.
   PubMed Web of Science ®Google Scholar
• Nishimoto Y, Yamakido M, Shigenobu T, Yukutake M, Matsusaka S. (1986). [Cancer of the respiratory tract observed in workers having retired from a poison gas factory]. Gan To Kagaku Ryoho 13:1144–1148.
   PubMedGoogle Scholar
• Noort D, Benschop HP, Black RM. (2002). Biomonitoring of exposure to chemical warfare agents: a review. Toxicol Appl Pharmacol 184:116–126.
   PubMed Web of Science ®Google Scholar
• Norman JE Jr. (1975). Lung cancer mortality in World War I veterans with mustard-gas injury: 1919-1965. J Natl Cancer Inst 54:311–317.
   PubMed Web of Science ®Google Scholar
• Notingher I, Imhof RE. (2004). Mid-infrared in vivo depth-profiling of topical chemicals on skin. Skin Res Technol 10:113–121.
   PubMed Web of Science ®Google Scholar
• Panahi Y, Motiei-Langroudi R, Alaeddini F, Naghizadeh MM, Aslani J, Ghanei M. (2008). Furosemide inhalation in dyspnea of mustard gas-exposed patients: a triple-blind randomized study. Inhal Toxicol 20:873–877.
   PubMed Web of Science ®Google Scholar
• Papirmeister B, Feister AJ, Robinson SI, Ford RD. (1991). Medical Defense against Mustard Gas. Boca Raton, FL: CRC Press.
   Google Scholar
• Papirmeister B, Gross CL, Meier HL, Petrali JP, Johnson JB. (1985). Molecular basis for mustard-induced vesication. Fundam Appl Toxicol 5:S134–S149.
   PubMedGoogle Scholar
• Pleyer U, Sherif Z, Baatz H, Hartmann C. (1999). Delayed mustard gas keratopathy: clinical findings and confocal microscopy. Am J Ophthalmol 128:506–507.
   PubMed Web of Science ®Google Scholar
• Rappeneau S, Baeza-Squiban A, Marano F, Calvet J. (2000). Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations. Toxicol Sci 58:153–160.
   PubMed Web of Science ®Google Scholar
• Ray P, Chakrabarti AK, Broomfield CA, Ray R. (2002). Sulfur mustard-stimulated protease: a target for antivesicant drugs. J Appl Toxicol 22:139–140.
   PubMedGoogle Scholar
• Requena L, Requena C, Sanchez M, Jaqueti G, Aguilar A, Sanchez-Yus E, Hernandez-Moro B. (1988). Chemical warfare. Cutaneous lesions from mustard gas. J Am Acad Dermatol 19:529–536.
   PubMed Web of Science ®Google Scholar
• Riazi A, Jadidi K, Naderi M, Karimi A, Babaei, M. (2004). Refractive errors as a late complication in sulfur mustard war victims. Mil Med 6:13–18.
   Google Scholar
• Richter MN, Wachtlin J, Bechrakis NE, Hoffmann F. (2006). Keratoplasty after mustard gas injury: clinical outcome and histology. Cornea 25:467–469.
   PubMed Web of Science ®Google Scholar
• Rosenthal DS, Simbulan-Rosenthal CM, Iyer S, Spoonde A, Smith W, Ray R, Smulson ME. (1998). Sulfur mustard induces markers of terminal differentiation and apoptosis in keratinocytes via a Ca2+-calmodulin and caspase-dependent pathway. J Invest Dermatol 111:64–71.
   PubMed Web of Science ®Google Scholar
• Ruhl CM, Park SJ, Danisa O, Morgan RF, Papirmeister B, Sidell FR, Edlich RF, Anthony LS, Himel HN. (1994). A serious skin sulfur mustard burn from an artillery shell. J Emerg Med 12:159–166.
   PubMedGoogle Scholar
• Safaei A, Saluti R, Kumar PV. (2001). Conjunctival dysplasia in soldiers exposed to mustard gas during the Iraq-Iran war: scrape cytology. Acta Cytol 45:909–913.
   PubMed Web of Science ®Google Scholar
• Safarinejad MR, Moosavi SA, Montazeri B. (2001). Ocular injuries caused by mustard gas: diagnosis, treatment, and medical defense. Mil Med 166:67–70.
   PubMed Web of Science ®Google Scholar
• Schnurr PP, Ford JD, Friedman MJ, Green BL, Dain BJ, Sengupta A. (2000). Predictors and outcomes of posttraumatic stress disorder in World War II veterans exposed to mustard gas. J Consult Clin Psychol 68:258–268.
   PubMed Web of Science ®Google Scholar
• Schnurr PP, Friedman MJ, Green BL. (1996). Post-traumatic stress disorder among World War II mustard gas test participants. Mil Med 161:131–136.
   PubMed Web of Science ®Google Scholar
• Shakil FA, Kuramoto A, Yamakido M, Nishimoto Y, Kamada N. (1993). Cytogenetic abnormalities of hematopoietic tissue in retired workers of the Ohkunojima poison gas factory. Hiroshima J Med Sci 42:159–165.
   PubMedGoogle Scholar
• Shohrati M, Aslani J, Eshraghi M, Alaedini F, Ghanei M. (2008). Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test. Respir Med 102:443–448.
   PubMed Web of Science ®Google Scholar
• Shohrati M, Davoudi SM, Keshavarz S, Sadr B, Tajik A. (2007). Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. Cutan Ocul Toxicol 26:249–255.
   PubMed Web of Science ®Google Scholar
• Shohrati M, Peyman M, Peyman A, Davoudi M, Ghanei M. (2007). Cutaneous and ocular late complications of sulfur mustard in Iranian veterans. Cutan Ocul Toxicol 26:73–81.
   PubMed Web of Science ®Google Scholar
• Sidell FR, Urbanetti JS, Smith WJ, Hurst CG. (1999). Vesicants. In Sidell FR, Takafuti ET, Franz DR, eds. Medical Aspects of Clinical and Biological Warfare. Washington, DC: Office of the Surgeon General, pp. 197–228.
   Google Scholar
• Smith WJ, Gross CL. (2002). Sulfur mustard medical countermeasures in a nuclear environment. Mil Med 167:101–102.
   PubMedGoogle Scholar
• Solberg Y, Alcalay M, Belkin M. (1997). Ocular injury by mustard gas. Surv. Ophthalmol., 41:461–466.
   PubMed Web of Science ®Google Scholar
• Somani SM, Babu SR. (1989). Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 27:419–435.
   PubMed Web of Science ®Google Scholar
• Stallard HB. (1940). An improvised eye-irrigator for use in the field. Br J Ophthalmol 24:53–57.
   PubMedGoogle Scholar
• Stone WL, Qui M, Smith M. (2003). Lipopolysaccharide enhances the cytotoxicity of 2-chloroethyl ethyl sulfide. BMC Cell Biol 4:1.
   PubMedGoogle Scholar
• Sun J, Wang YX, Sun MJ. (1999). Apoptosis and necrosis induced by sulfur mustard in Hela cells. Zhongguo Yao Li Xue Bao 20:445–448.
   PubMed Web of Science ®Google Scholar
• Szinicz L. (2005). History of chemical and biological warfare agents. Toxicology 214:167–181.
   PubMed Web of Science ®Google Scholar
• Thomsen AB, Eriksen J, Smidt-Nielsen K. (1998). Chronic neuropathic symptoms after exposure to mustard gas: a long-term investigation. J Am Acad Dermatol 39:187–190.
   PubMed Web of Science ®Google Scholar
• van der Schans GP, Noort D, Mars-Groenendijk RH, Fidder A, Chau LF, de Jong LP, Benschop HP. (2002). Immunochemical detection of sulfur mustard adducts with keratins in the stratum corneum of human skin. Chem Res Toxicol 15:21–25.
   PubMedGoogle Scholar
• Vidan A, Luria S, Eisenkraft A, Hourvitz A. (2002). Ocular injuries following sulfur mustard exposure: clinical characteristics and treatment. Isr Med Assoc J 4:577–578.
   PubMed Web of Science ®Google Scholar
• Wang GQ, Xia ZF. (2007). Tissue injury by hot fluid containing nitrogen mustard. Burns 33:923–926.
   PubMedGoogle Scholar
• Watson AP, Griffin GD. (1992). Toxicity of vesicant agents scheduled for destruction by the Chemical Stockpile Disposal Program. Environ Health Perspect 98:259–280.
   PubMed Web of Science ®Google Scholar
• Willems JL. (1989). Clinical management of mustard gas casualties. Medicinae Militaris (Belgicae) 3:161.
   Google Scholar
• Withman LB. (1918). Military ophthalmology.
   Google Scholar
• Zhang Z, Peters BP, Monteiro-Riviere NA. (1995). Assessment of sulfur mustard interaction with basement membrane components. Cell Biol Toxicol 11:89–101.
   PubMed Web of Science ®Google Scholar
• Zikler T. (2005). Medical management of incidents with chemical warfare agents. Toxicology 214:221–231.
   PubMedGoogle Scholar